A Provisional Document. The purpose of this manual is to provide guidance to public health professionals tasked with managing a response to viral hepatitis. As every country’s needs are different with respect to its epidemiology and the current level of response, people would use this manual in di...fferent ways
more
WHO
Considering programmatic implications of rising levels of HIV drug resistance: finalizing the Global Action Plan
Webinars 12 13 Dec 2016
Application of a One Health approach .
The present guidance was developed with the support of the WHO Advisory Group on Integrated Surveillance of Antimicrobial Resistance (AGISAR) to assist countries and other stakeholders in the establishment and development of programmes of integrated surveillan...ce of antimicrobial resistance in the foodborne bacteria (i.e., bacteria commonly transmitted by food) by taking a One Health approach.
more
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...or International Drug Monitoring (PIDM) and other partners, which was held on 20 October 2022.
more
This toolkit is a "how to" guide for developing, implementing and evaluating a multisectoral action plan for prevention and control of NCDs. It is targeted at policy-makers, planners and programme managers, and is intended to help countries, provinces and cities meet the requirements for achieving g...lobal and national NCD targets and the Sustainable Development Goals. The toolkit takes the user through a series of actions related to the development of a multisectoral action plan ("MSAP development actions"), and provides forms and a template framework for users to complete as they undertake these actions. Developing a multisectoral action plan involves establishing health needs and engaging relevant stakeholders before determining the actions to take, identifying and prioritizing interventions, deciding on ways to address NCDs while establishing support and resources for prevention and control, and evaluating progress in implementing the plan.
more
Handle Antimicrobials with care, we can help!
La lista OMS de AIC categoriza la totalidad de los antimicrobianos utilizados en el ser humano en tres grupos en función de su importancia para la medicina humana. Por el momento se limita a los fármacos antibacterianos, muchos de los cuales también se utilizan en la medicina v...eterinaria.El objetivo de la lista es contribuir a gestionar la resistencia a los antimicrobianos y garantizar que todos los antimicrobianos, sobre todo los de importancia crítica, se utilicen de forma prudente en la medicina tanto humana como veterinaria.
more
La RAM se produce cuando los microorganismos (bacterias, hongos, virus y parásitos) sufren cambios al verse expuestos a los antimicrobianos (antibióticos, antifúngicos, antivíricos, antipalúdicos o antihelmínticos, por ejemplo). Los microorganismos resistentes a la mayoría de los antimicrobia...nos se conocen como ultrarresistentes.
Como resultado, los medicamentos se vuelven ineficaces y las infecciones persisten en el organismo, lo que incrementa el riesgo de propagación a otras personas.
more
WHO clinical and policy guidelines
The document provides guidance on managing acute diarrhoea outbreaks, specifically cholera and shigellosis. It outlines steps for identifying outbreaks, differentiating between cholera and shigellosis, and treating patients based on the severity of dehydration. Recommendations include the use of ora...l rehydration solutions (ORS), antibiotics in severe cases, and strict hygiene practices to prevent transmission. The document also emphasizes community protection measures such as disinfection of water sources, isolation of cases, and proper food hygiene. It is a practical resource for health workers to quickly respond to diarrhoeal disease outbreaks.
more
The aim of this document is to provide interim guidance for interventions to reduce the risk of maternal Zika virus infection and to manage potential complications during pregnancy. This guidance is based on the best available research evidence and covers areas prioritized by an international, multi...disciplinary group of health care professionals and other stakeholders. Specifically, it presents guidance for preventing Zika virus infection;antenatal care and management of women with infection; and care during pregnancy for all pregnant women living in affected areas, with the aim of optimizing health outcomes for mothers and newborns.
more